Integer Holdings Corp
Integer Holdings Corp. is a U.S.-based contract development and manufacturing organization focused on medical devices for cardio and vascular, neuromodulation, and cardiac rhythm management markets. It designs and manufactures custom components, assemblies, and system/device solutions for large multinational OEMs, combining engineering, manufacturing, and quality systems under brands such as Greatbatch Medical and Lake Region Medical.
Tilikausi 2025 · muutos edellisvuodesta
Kehitys 2020–2025
Liiketoiminta
Osuus liikevaihdostaCustom components, assemblies, and manufacturing services for cardiovascular devices.
Manufacturing and engineering support for neuromodulation device platforms.
Production of components and assemblies used in rhythm management devices.
Ready-to-market device solutions developed with OEM customers.
Design, materials selection, process engineering, and program support.
Tuotteet
Raportoitu · osuus liikevaihdosta- Cardio and Vascular59,7 %
- Cardiac Rhythm Management Neuromodulation36,1 %
- Other Markets4,2 %
Lähde: 10-K FY2025, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.
Asiakkaat
Integer sells primarily to large multinational medical device OEMs and their affiliated subsidiaries, with direct sales and long-term supply relationships. Its customers buy because Integer can provide specialized manufacturing, engineering, and quality capabilities that are difficult to replicate in-house, especially for regulated implantable and therapy-delivery devices. Customer concentration is high, with Abbott Laboratories, Boston Scientific, and Medtronic each representing more than 10% of 2025 sales.
Buy custom components, assemblies, and device solutions for branded medical devices; they value scale, quality, and regulatory execution.
Source products through affiliated entities and regional programs, often tied to global supply agreements.
Buy specialized manufacturing for cardiovascular therapies and related components.
Buy manufacturing and engineering support for implantable and therapy-delivery platforms.
Buy components and assemblies used in pacemakers and related rhythm management products.
Strategia
Integer is shifting toward higher-growth medtech markets where it has differentiated engineering and manufacturing capabilities. It is also using tuck-in acquisitions to add technologies, expand customer penetration, and deepen its position in targeted therapy areas while maintaining a focus on quality and service. The strategy is designed to strengthen scale, broaden capabilities, and reduce dependence on any single product line or customer.
These markets offer stronger long-term demand and fit Integer's engineering and manufacturing strengths.
Acquisitions add capabilities, brands, and technologies that deepen customer relationships and broaden the platform.
Longer contracts help secure the revenue base and improve visibility in a concentrated customer model.
Maantiede
2025Integer is headquartered in Plano, Texas and sells globally, but its customer base is heavily tied to U.S.-headquartered OEMs. In 2025, approximately 53% of products sold were shipped to locations in the United States, showing that the business is operationally concentrated in the U.S. even when end markets are international. Geography matters because supply-chain execution, customer proximity, and regulatory compliance are central to its CDMO model.
Osuus liikevaihdosta, jonka yhtiö raportoi maantieteellisesti.
Riskit
Integer's biggest risk is customer concentration: a small number of OEMs account for a large share of revenue, so demand changes, sourcing shifts, or vertical integration by customers can quickly affect results. The business also faces pricing pressure, product recall exposure through customer programs, cybersecurity and IT disruption risk, and integration risk from acquisitions. As a regulated medical-device supplier, quality failures or supply interruptions can damage customer relationships and lead to lost programs.
- Customer concentrationVaikutus: KorkeaTodennäköisyys: Korkea
Top three customers were about 49% of 2025 sales, so loss or reduction of one account would materially affect revenue.
Kohdistuu - Pricing pressureVaikutus: KorkeaTodennäköisyys: Kohtalainen
OEM customers can demand price reductions, which can reduce operating margins in a contract manufacturing model.
Kohdistuu: Contract renewals and annual pricing negotiations
- Cybersecurity and IT disruptionVaikutus: KeskitasoTodennäköisyys: Kohtalainen
A breach or outage could interrupt manufacturing, expose data, or trigger regulatory and legal costs.
Kohdistuu - Customer inventory and sourcing changesVaikutus: KeskitasoTodennäköisyys: Matala
Inventory rebalancing, vertical integration, or alternate supply arrangements can reduce shipments unexpectedly.
Kohdistuu: Program-level demand volatility
- Acquisition integration riskVaikutus: KeskitasoTodennäköisyys: Matala
Recent acquisitions must be integrated without disrupting operations or eroding expected synergies.
Kohdistuu
Kirjanpito
Harkinnanvaraiset erätManagement must estimate obsolete or excess inventory and lower-of-cost-or-net-realizable-value adjustments.
Vaikutus: Can change gross margin and earnings if demand shifts or products become unsaleable
Recent tuck-in acquisitions create purchase accounting allocations and potential impairment risk.
Vaikutus: Affects amortization expense, goodwill balance, and future impairment charges
Debt issuance, exchanges, and capped calls require careful classification and valuation.
Vaikutus: Affects interest expense, equity classification, and diluted EPS
Sales are driven by customer shipments and program demand, which can shift between periods.
Vaikutus: Can create quarterly volatility in revenue and margins
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
iRhythm Holdings, Inc.
IRTC · Surgical & Medical Instruments & Apparatus
IR-Med, Inc.
Electromedical & Electrotherapeutic Apparatus
Medtronic plc
MDT · Electromedical & Electrotherapeutic Apparatus
Medtronic plc designs, manufactures, and sells medical technologies used to diagnose, treat, and manage chronic and acute conditions across the body.
Abbott Laboratories
ABT · Pharmaceutical Preparations
Abbott Laboratories is a U.S.-based healthcare company that discovers, develops, manufactures, and sells a diversified portfolio spanning medical devices,…
iRadimed Corporation
IRMD · Surgical & Medical Instruments & Apparatus
IRADIMED Corp designs and sells MRI-compatible medical devices used inside scanner rooms, centered on infusion pumps, patient vital signs monitoring systems, and related disposables and service.
Tenet Healthcare Corporation
THC · Services-General Medical & Surgical Hospitals, NEC
Päivitetty: 24.9.2026